RELAY THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
On April 15, 2021, Relay Therapeutics, Inc. (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") by and among the Company, Elixir Merger Sub I, Inc., a Delaware corporation and a wholly-owned direct subsidiary of the Company ("First Merger Sub"), Elixir Merger Sub II, LLC, a Delaware limited liability company and a wholly-owned direct subsidiary of the Company ("Second Merger Sub" and together with First Merger Sub, the "Merger Subs"), ZebiAI Therapeutics, Inc., a Shareholder Representative Services LLC, a Colorado limited liability company, solely in i...
Source: marketscreener.com
